Brief: Cantargia To Present Promising Nadunolimab Efficacy In Non-Small Cell Lung Cancer

Cantargia AB

26/05/2023 07:52

May 26 (Reuters) - Cantargia  CANTA.ST :
    * CANTARGIA TO PRESENT PROMISING NADUNOLIMAB EFFICACY IN
NON-SMALL
CELL LUNG CANCER
    * RESULTS HAVE DEMONSTRATED IMPROVEMENT SINCE THE PREVIOUS
UPDATE
WITH OBJECTIVE RESPONSE RATE (ORR), PROGRESSION-FREE SURVIVAL
(PFS) AND OVERALL SURVIVAL (OS) COMPARING VERY FAVORABLY TO
HISTORICAL DATA FOR CHEMOTHERAPY ALONE
    * TWO NON-SQUAMOUS NSCLC PATIENTS WITH SIMILAR BIOMARKER
PROFILES
ACHIEVED COMPLETE RESPONSE, INCLUDING ONE PATIENT DURING
NADUNOLIMAB MONOTHERAPY AFTER TERMINATION OF CHEMOTHERAPY

        
 Source text for Eikon:  urn:newsml:reuters.com:*:nNDL3mZNR4
 Further company coverage:  CANTA.ST  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))